The HIV Infected Neonate (< 1 Month of Age)
Description Medicine treatment ICD-10 codes: B20-B24 DESCRIPTION Defined as an infant < 1 month of age, in whom HIV infection has been confirmed with two appropriate tests. For confirmation of HIV infection, see: Human immunodeficiency virus infections . MEDICINE TREATMENT This treatment protocol is meant as a guide, and there is allowance for flexibility after discussion with
Description
Medicine treatment
ICD-10 codes: B20-B24
DESCRIPTION
Defined as an infant < 1 month of age, in whom HIV infection has been confirmed with two appropriate tests. For confirmation of HIV infection, see: Human immunodeficiency virus infections.
MEDICINE TREATMENT
This treatment protocol is meant as a guide, and there is allowance for flexibility after discussion with an expert.

Click on image to enlarge

Click on image to enlarge
Caregivers administering ARV medication to the child must be supplied with a syringe (1 mL or 2 mL) for each of the three ARVs and shown how to prepare and administer the correct dose. If possible, bottles and syringes should be colour-coded with stickers, and a sticker of the relevant colour should be used to mark the correct dose on the syringe.
Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Paediatrics, 2023 Edition
Chapter 9: Human Immunodeficiency Virus Infections, 9.1.2 The HIV-Infected Neonate (< 1 Month Of Age)
ICD-10 codes
- B20.0HIV disease resulting in mycobacterial infection
- B20.1HIV disease resulting in other bacterial infections
- B20.2HIV disease resulting in cytomegaloviral disease
- B20.3HIV disease resulting in other viral infections
- B20.4HIV disease resulting in candidiasis
- B20.5HIV disease resulting in other mycoses
- B20.6HIV disease resulting in Pneumocystis jirovecii pneumonia
- B20.7HIV disease resulting in multiple infections
- B20.8HIV disease resulting in other infectious and parasitic diseases
- B20.9HIV disease resulting in unspecified infectious or parasitic disease
- B21.0HIV disease resulting in Kaposi's sarcoma
- B21.1HIV disease resulting in Burkitt lymphoma
- B21.2HIV disease resulting in other types of non-Hodgkin lymphoma
- B21.3HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
- B21.7HIV disease resulting in multiple malignant neoplasms
- B21.8HIV disease resulting in other malignant neoplasms
- B21.9HIV disease resulting in unspecified malignant neoplasm
- B22.0HIV disease resulting in encephalopathy
- B22.1HIV disease resulting in lymphoid interstitial pneumonitis
- B22.2HIV disease resulting in wasting syndrome
- B22.7HIV disease resulting in multiple diseases classified elsewhere
- B23.0Acute HIV infection syndrome
- B23.1HIV disease resulting in (persistent) generalized lymphadenopathy
- B23.2HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
- B23.8HIV disease resulting in other specified conditions
- B24Unspecified human immunodeficiency virus [HIV] disease